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In this issue of Chemistry & Biology, Arrendale and coworkers demonstrate a new prodrug
strategy for intracellular delivery of an α, α-(difluoromethylene)phosphonate phosphoserine
mimic. The deprotected pseudo-phosphopeptide releases the pro-apoptotic FOXO3a-transcription
factor from its 14-3-3-adaptor protein complex, resulting in leukemic cell death.
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Signal transduction in nature often involves protein phosphorylation. The combination of
kinetic stability and thermodynamic lability of the phosphate ester renders it an excellent
switch. Much of the kinetic stability to nucleophilic attack presumably derives from the
negatively charged phosphoryl oxygens in its predominantly dianionic form (pKa2 ~6.5).
Because of the ubiquity of phosphorylation as a signaling mechanism, chemical biologists
have long sought to synthesize compounds that structurally and functionally mimic
phosphate ester functionality but are resistant to phosphatase cleavage. Replacing the
bridging oxygen with carbon confers such resistance, but simple CH2-bridged phosphonates
have an elevated second pKa (7–7.5), exhibiting considerable monoanionic character.
However, upon α-fluorination, the second pKa successively decreases in going from a CHF(pKa ~6–6.5) to a CF2-bridge (pKa ~5–5.5). At the same time, C-C(H)(F)-P bond angle
increases [e.g., from 112° (CH2) to 113° (CHF) to 117° (CF2) in a series studied by
Nieschalk et al. (1996)], reaching an angle very close to the native C-O-P angle (119°) for
the difluorinated phosphonate.
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Such considerations led (Caplan et al. (2000) and others to regard α, α(difluoromethylene)phosphonates as “isopolar” and “isosteric” phosphate analogs. While the
CF2-bridge clearly projects a larger van der Waals radius than the native bridging O, the fact
that it expands the C-CF2-P bond angle lends some merit to the label “isosteric.” The
“isopolar” nature of this functionality, on the other hand, is supported by DFT calculations
on simple model compounds (Figure 1). The partial charge on the bridging phosphate ester
oxygen (−0.453) is mimicked by the bridging CF2-phosphonate carbon (−0.395), especially
when one considers the additional charge density on the pendant fluorines (−0.172 each).
Accordingly, in the 1990s, our group developed CF2-phosphonate analogs of pSer and pThr
(Berkowitz et al., 1996, 1999) as tools for the study of protein phosphorylation (abbreviated
pCF2-Ser; Panigrahi et al., 2009). Recent years have seen the very creative application of
these tools. One particularly compelling use is to modulate protein-protein interactions

*

Correspondence: dberkowitz1@unl.edu.

Panigrahi et al.

Page 2

Author Manuscript

(PPIs) that depend upon Ser/Thr phosphorylation. Paramount among these are the
interactions of 14-3-3 adaptor proteins, ubiquitous “chaperones” that bind to phosphorylated
partner proteins to modulate signal transduction, the cell cycle, intracellular trafficking and
transcription.
Obsil et al. (2001) solved a prototypical 14-3-3-adaptor/phosphorylated-partner protein
complex structure. The structure reveals in beautiful molecular detail how the
phosphothreonine residue of the AANAT is tightly bound at a groove in the 14-3-3 dimer
interface that is rich in H-bond donating residues, Y128, R86, and R127, resulting in a
“molecular Velcro”-like interaction. The two arginine residues also appear to
electrostatically pair with the pThr dianion, making this an ideal site to target with the CF2phosphonate functionality.
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With the appearance of the paper in this issue of Chemistry & Biology by Arrendale et al.
(2012), now two complementary approaches exist that, taken together, attest to the abililty
of pCF2-Ser-bearing ligands to modulate 14-3-3-mediated PPIs. In earlier work, Zheng et al.
(2005) modified the native protein itself, AANAT, using expressed protein ligation (EPL)
technique to graft the phosphatase-inert pCF2-Ser residue onto position 205 of the wild-type
protein. This effectively leads to a “constitutively phosphorylated” AANAT, remaining
closely associated with its 14-3-3-zeta binding partner, and thereby stabilizing the protein to
proteasomal degradation. In fact, using microinjection into CHO cells, Zheng et al. (2005)
saw the persistence of this tight pCF2-Ser/14-3-3 interaction under intracellular conditions.
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Very recently, Tarrant et al. (2012) have shown that this same strategy can be exploited to
stabilize the important signal-transducing casein kinase II (CK2) kinase involved in cell
proliferation. In this case, the PPI being targeted involves the CK2 interaction with the
regulatory protein, Pin1. The CK2-Pin1 association is promoted by phosphorylation of
Thr-344. Again utilizing EPL to incorporate pCF2-Ser at this site, Tarrant et al. (2012) were
able to show that the semisynthetic CK2 binds tightly to its Pin1 regulatory protein partner,
and that this interaction both stabilizes the protein to proteasomal degradation and alters its
polypeptide substrate specificity.
Herein, Arrendale et al. (2012) first reports a new, efficient stereocontrolled synthesis of the
pCF2-Ser building block, utilizing a nice stereo-retentive aziridine-opening. Arrendale et al.
(2012) then truly open up a new vista in the application of this chemical biological tool by
installing one of their trademark prodrug functionalities onto the fluorinated phosphonate
and using this to deliver a carefully crafted pCF2-Ser-containing dipeptide ligand for the
14-3-3 adaptor protein into the cell.
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The elegant presumptive phosphonate release mechanism is depicted in Figure 2. The 5′nitrofuryl-2′-methyl N(4″-chlorobutyl)phosphonamido ester prodrugging strategy masks the
fluorinated phosphonate as a neutral non-polar derivative, and subsequently promotes its
release under reducing conditions within the cell. Reductive cleavage of the phosphonate
ester, and subsequent ionization places more electron density on the amide nitrogen,
permitting a Baldwin's rules-favored 5-exo-tet cyclization to a pyrrolidinium ring, also an
excellent leaving group. Hydrolysis and ionization then give the free phosphonate dianion.
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In the case at hand, the released modified dipeptide ligand successfully competes, in vivo,
with the phosphorylated FOXO3a transcription factor for its 14-3-3 adaptor protein, thereby
effectively titrating off the adaptor at micromolar ligand concentrations. Applied to
leukemia cells, the authors show that this 14-3-3-sequestering strategy can be used to induce
the pro-apoptotic effects of the free FOXO3a protein, with attendant anti-leukemic activity.
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These studies expand the domain in which such “teflon phosphates” may be deployed to ask
fundamental questions in chemical biology, allowing for their transport into the cell. Given
recent exciting developments in photocaging/release of native pSer functionality from the
Imperiali lab (Goguen et al., 2011), it will be interesting to see if this strategy can be
expanded to include wavelength specific photolabile prodrug functionalities for pCF2Ser.
One can imagine thusly asking more finely tuned questions relating to the temporal
regulation of protein function via phosphorylation. Clearly, given the abundance of 14-3-3
adaptor protein-mediated regulatory interactions, both this work and the complementary
protein-grafting work in the Cole group open up important horizons for the interrogation of
phosphorylation-dependent PPIs with this chemical biological tool.
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Figure 1. Fluorinated Phosphonates versus Phosphates: A Computational Comparison

Electrostatic potential (ESP) maps were generated from DFT calculations with Gaussian
03W using the B3LYP function at the 6-311+g(d,p) level. Calculations were performed on
full ground state optimizations, plus frequencies. ESP maps were generated in Gaussview
3.0. Isosurfaces were generated with a total charge density of 0.0004 e/bohr. Note that the
charge distribution shown is for the minimum energy conformer located. At room
temperature, rapid single bond rotation should lead to equal charge distribution across the
three anionic phosph(on)ate oxygens.
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Figure 2. Prodrug Release Mechanism

Depicted is the putative mechanism of intracellular prodrug activation, under reductive
conditions, for the pCF2-Ser-containing dipeptide ligand for the 14-3-3 adapter protein.
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